biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Saltarelli is in the catbird seat...

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Jan 10, 2023 11:08am

98 Views

Post# 35213375

RE:RE:RE:RE:RE:Saltarelli is in the catbird seat...

Unlike Rathjen, narmac, Saltarelli may have had the good graces not to grin and gloat at the funeral, I mean, webinar.

As Macbeth said, "False face must hide what the false heart doth know."

Maybe Saltarelli is well=practiced at telling us that "It hurts me more than it does you."

Nah, not buying into that, Mario.

jd

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta